Fibromyalgia

Immersive virtual reality with biofeedback shows promise in reducing fibromyalgia pain and enhancing quality of life, paving the way for future studies.

A recent study reveals that anti-CGRP monoclonal antibodies effectively treat migraines in fibromyalgia patients, improving headache frequency and disability.

COVID-19 vaccination had a particularly protective effect in males and those with anxiety or depression.

A new meta-analysis reveals aquatic exercise and resistance training as the top therapeutic exercises for reducing fibromyalgia pain in women.

New findings highlight the link between fibromyalgia syndrome and increased rates of astigmatism, dry eye disease, and meibomian gland dysfunction.

These preliminary findings on psilocybin-assisted therapy (PAT) for patients with fibromyalgia point to its potential, though additional large-scale research is needed.

Somatization syndromes and childhood trauma emerged as key predictors of fibromyalgia over rheumatoid arthritis in a recent study comparing both groups.

Recent research highlights low certainty in sleep interventions for fibromyalgia, yet exercise shows promise in improving sleep quality.

New findings suggest the 2016 criteria may underdiagnose fibromyalgia in patients with comorbidities, potentially missing the disorder’s full clinical complexity.

Participants experienced significant improvements in pain, sleep, and physical function.

After a primary analysis revealed no significant differences in pain, exploratory outcomes in the FINAL trial also revealed no significant findings.

Our Q1 2025 recap for rheumatology spotlights 5 regulatory updates, 5 key trial announcements, and top expert perspectives in rheumatology care.

The rheumatology month in review emphasizes new research in gout, fibromyalgia, and psoriatic arthritis.

The rheumatology month in review emphasizes new research in gout, fibromyalgia, and psoriatic arthritis.

The two treatments appeared to be similar in cost-effectiveness and efficacy in a small analysis.

Analgesic effects lasted up to week 8 while function improvements lasted until week 16 in a new randomized, controlled trial.

Geraniol, linalool or α-humulene elevated mechanical thresholds in a time-dependent fashion in mice models of pain.

The rheumatology month in review emphasizes new research in gout, fibromyalgia, and lupus.

Copper had a positive association with FM risk and iron had a negative association.

Stanza previously demonstrated efficacy in helping to manage fibromyalgia in adult patients when compared with digital symptom tracking in phase 3 data.

Endocrinological stress indicators were not associated with perceived stress, which was related to symptom severity.

The rheumatology month in review emphasizes new research in gout, fibromyalgia, and psoriatic arthritis.

People with inflammatory bowel disease and FM tended to have a higher disease duration and reported higher rates of fatigue and lower QoL.

The lower BHI observed was likely associated with effects on the musculoskeletal system and not the central nervous system.